메뉴 건너뛰기




Volumn 11, Issue 4, 2010, Pages 480-481

Transmyocardial laser revascularization 12 years later

Author keywords

Coronary surgery; Myocardial ischemia; Transmyocardial laser revascularization

Indexed keywords

AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; MALE; MORTALITY; NEOPLASM; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 78249273638     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.243618     Document Type: Article
Times cited : (6)

References (5)
  • 5
    • 0036843674 scopus 로고    scopus 로고
    • The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts
    • Lutter G, Attman T, Heilmann C, von Samson P, von Specht B, Beyersdorf F. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. Eur J Cardiothorac Surg 2002;22:753-761.
    • (2002) Eur J Cardiothorac Surg , vol.22 , pp. 753-761
    • Lutter, G.1    Attman, T.2    Heilmann, C.3    von Samson, P.4    von Specht, B.5    Beyersdorf, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.